TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 12-31. Amounts in USD.

Revenue Quarterly

0 2B 4B 6B Q3 '24: 4.3B Q4 '24: 4.2B Q1 '25: 3.9B Q2 '25: 4.2B Q3 '25: 4.5B Q4 '25: 4.7B Q1 '26: 4B Q2 '26: 4.1B Q3 '24 Q4 '24 Q1 '25 Q2 '25 Q3 '25 Q4 '25 Q1 '26 Q2 '26

Gross Profit Quarterly

0 1B 2B 3B Q3 '24: 2.1B Q4 '24: 2.1B Q1 '25: 1.9B Q2 '25: 2.1B Q3 '25: 2.3B Q4 '25: 2.7B Q1 '26: 2B Q2 '26: 2.2B Q3 '24 Q4 '24 Q1 '25 Q2 '25 Q3 '25 Q4 '25 Q1 '26 Q2 '26

Operating Income Quarterly

-300M 0 300M 600M 900M Q3 '24: -51M Q4 '24: -29M Q1 '25: 519M Q2 '25: 455M Q3 '25: 882M Q4 '25: 300M Q1 '26: 652M Q2 '26: -231M Q3 '24 Q4 '24 Q1 '25 Q2 '25 Q3 '25 Q4 '25 Q1 '26 Q2 '26

Net Income Quarterly

-600M -400M -200M 0 200M 400M 600M Q3 '24: -437M Q4 '24: -217M Q1 '25: 214M Q2 '25: 282M Q3 '25: 433M Q4 '25: 480M Q1 '26: 369M Q2 '26: -576M Q3 '24 Q4 '24 Q1 '25 Q2 '25 Q3 '25 Q4 '25 Q1 '26 Q2 '26

Cost of Revenue Quarterly

0 800M 1.6B 2.4B Q3 '24: 2.2B Q4 '24: 2.1B Q1 '25: 2B Q2 '25: 2.1B Q3 '25: 2.2B Q4 '25: 2.1B Q1 '26: 2B Q2 '26: 2B Q3 '24 Q4 '24 Q1 '25 Q2 '25 Q3 '25 Q4 '25 Q1 '26 Q2 '26

Operating Cash Flow Quarterly

-400M 0 400M 800M 1.2B Q3 '24: 693M Q4 '24: 575M Q1 '25: -105M Q2 '25: 227M Q3 '25: 369M Q4 '25: 1.2B Q1 '26: -40M Q2 '26: 411M Q3 '24 Q4 '24 Q1 '25 Q2 '25 Q3 '25 Q4 '25 Q1 '26 Q2 '26

Free Cash Flow Quarterly

-350M 0 350M 700M 1.1B Q3 '24: 545M Q4 '24: 446M Q1 '25: -232M Q2 '25: 131M Q3 '25: 233M Q4 '25: 1B Q1 '26: -208M Q2 '26: 307M Q3 '24 Q4 '24 Q1 '25 Q2 '25 Q3 '25 Q4 '25 Q1 '26 Q2 '26

Operating cash flow minus capital expenditure.

Shares Outstanding Quarterly

0 500M 1B 1.5B Q1 '24: 1.1B Q2 '24: 1.1B Q3 '24: 1.1B Q1 '25: 1.2B Q2 '25: 1.2B Q3 '25: 1.2B Q1 '26: 1.2B Q2 '26: 1.2B Q1 '24 Q2 '24 Q3 '24 Q1 '25 Q2 '25 Q3 '25 Q1 '26 Q2 '26

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

-1.50 -1.00 -0.50 0.00 0.50 1.00 1.50 Q3 '24: -0.84 Q4 '24: -1.45 Q1 '25: -1.15 Q2 '25: -0.16 Q3 '25: 0.60 Q4 '25: 1.20 Q1 '26: 1.33 Q2 '26: 0.60 Q3 '24 Q4 '24 Q1 '25 Q2 '25 Q3 '25 Q4 '25 Q1 '26 Q2 '26

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.